Zhejiang Dayang Biotech Group Co (003017) - Total Liabilities
Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has total liabilities worth CN¥706.73 Million CNY (≈ $103.42 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Zhejiang Dayang Biotech Group Co net asset momentum to track the company's year-over-year net asset growth rate.
Zhejiang Dayang Biotech Group Co - Total Liabilities Trend (2013–2025)
This chart illustrates how Zhejiang Dayang Biotech Group Co's total liabilities have evolved over time, based on quarterly financial data. See 003017 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Zhejiang Dayang Biotech Group Co Competitors by Total Liabilities
The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Guangdong Jushen Logistics Co Ltd
SHE:001202
|
China | CN¥1.03 Billion |
|
SOLiD Inc
KQ:050890
|
Korea | ₩183.33 Billion |
|
Qingdao Victall Railway Co Ltd
SHG:605001
|
China | CN¥2.47 Billion |
|
Deva Holding AS
IS:DEVA
|
Turkey | TL9.02 Billion |
|
Precious Shipping Public Company Limited
BK:PSL-R
|
Thailand | ฿9.21 Billion |
|
Oponeo.pl SA
WAR:OPN
|
Poland | zł1.13 Billion |
|
Seah Holdings
KO:058650
|
Korea | ₩3.31 Trillion |
|
Nalwa Sons Investments Limited
NSE:NSIL
|
India | Rs19.65 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Zhejiang Dayang Biotech Group Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Zhejiang Dayang Biotech Group Co worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Dayang Biotech Group Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Dayang Biotech Group Co (2013–2025)
The table below shows the annual total liabilities of Zhejiang Dayang Biotech Group Co from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥681.72 Million ≈ $99.76 Million |
+13.54% |
| 2024-12-31 | CN¥600.40 Million ≈ $87.86 Million |
+11.50% |
| 2023-12-31 | CN¥538.47 Million ≈ $78.79 Million |
+2.97% |
| 2022-12-31 | CN¥522.92 Million ≈ $76.52 Million |
+36.31% |
| 2021-12-31 | CN¥383.64 Million ≈ $56.14 Million |
+41.74% |
| 2020-12-31 | CN¥270.67 Million ≈ $39.61 Million |
+83.49% |
| 2019-12-31 | CN¥147.51 Million ≈ $21.59 Million |
-8.37% |
| 2018-12-31 | CN¥160.99 Million ≈ $23.56 Million |
-8.20% |
| 2017-12-31 | CN¥175.37 Million ≈ $25.66 Million |
-26.12% |
| 2016-12-31 | CN¥237.37 Million ≈ $34.73 Million |
-4.72% |
| 2015-12-31 | CN¥249.12 Million ≈ $36.45 Million |
-6.50% |
| 2014-12-31 | CN¥266.43 Million ≈ $38.99 Million |
+4.92% |
| 2013-12-31 | CN¥253.93 Million ≈ $37.16 Million |
-- |
About Zhejiang Dayang Biotech Group Co
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium carbonate and chloride, ammonium chloride, and bicarbonate food and feed additives; industrial grade potassium carbonate and bicarbonate; and agricultural and industrial grade ammonium chloride. It also provide… Read more